Inherent Biosciences

Inherent Biosciences

Signal active

Organization

Contact Information

Overview

Inherent Biosciences is a molecular diagnostics company that revolutionizes trial and error medicine and restore hope. The company does this by discovering what's inherent in our biology about the unexplained and translating discoveries into personal insights that inform actions.

Inherent Biosciences develops medicines for treating pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, COVID-19, and many more.

About

Industries

Biotechnology, Health Care, Therapeutics

Founded

2019

Employees

1-10

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Inherent Biosciences headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $129.4M in funding across 60 round(s). With a team of 1-10 employees, Inherent Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Inherent Biosciences, raised $1.9M. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

5

Investors

1

Lead Investors

0

Total Funding Amount

$2.2M

Details

2

Inherent Biosciences has raised a total of $2.2M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2021Seed
2022Early Stage Venture

Investors

Inherent Biosciences is funded by 20 investors.

Investor NameLead InvestorFunding RoundPartners
Inherent Biosciences-FUNDING ROUND - Inherent Biosciencesundefined
Portfolia-FUNDING ROUND - Portfoliaundefined
Inherent Biosciences-FUNDING ROUND - Inherent Biosciences1.9M
National Institutes of Health-FUNDING ROUND - National Institutes of Health1.9M

Recent Activity

There is no recent news or activity for this profile.